![Vijay Iyengar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vijay Iyengar
Präsident bei
HistoRx, Inc.
Vermögen: 4 Mio $ am 31.05.2026
Profil
Vijay Iyengar is currently President at HistoRx, Inc. Former positions include EVP, Head-Global Medical Affairs & Product at Incyte Corp.
from 2016 to 2025; President at Genoptix, Inc. from 2014 to 2016; Vice President & Head-Rare Disease at Novartis Oncology, Inc. from 2011 to 2014; Vice President & General Manager at Novartis Hellas SACI from 2009 to 2011; Executive Director-Global Brand at Novartis Pharmaceuticals Corp.
from 2007 to 2009; and Engagement Manager at McKinsey & Co., Inc. Education includes undergraduate studies at Stanford University and a doctorate from Harvard Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INCYTE CORPORATION 0,02 % | 16.07.2025 | 40 540 ( 0,02 % ) | 4 Mio $ | 31.05.2026 |
Aktive Positionen von Vijay Iyengar
| Unternehmen | Position | Beginn |
|---|---|---|
HistoRx, Inc.
 HistoRx, Inc. Medical SpecialtiesHealth Technology Develops tissue-based diagnostic products | Präsident | - |
Ehemalige bekannte Positionen von Vijay Iyengar
| Unternehmen | Position | Ende |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 31.12.2025 |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Präsident | 01.04.2016 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01.03.2014 |
Novartis Hellas SACI
 Novartis Hellas SACI Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to improve and extend people's lives | Corporate Officer/Principal | 01.12.2011 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01.06.2009 |
Ausbildung von Vijay Iyengar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
56
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
HistoRx, Inc.
HistoRx, Inc. Medical SpecialtiesHealth Technology Develops tissue-based diagnostic products | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Hellas SACI
Novartis Hellas SACI Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to improve and extend people's lives | Health Technology |
Wählen Sie MarketScreener 
